BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 49 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $295,000 | +4.2% | 275,000 | +1.9% | 0.15% | -5.1% |
| Q3 2020 | $283,000 | +1472.2% | 270,000 | +1700.0% | 0.16% | +1633.3% |
| Q2 2020 | $18,000 | +12.5% | 15,000 | 0.0% | 0.01% | -10.0% |
| Q1 2020 | $16,000 | 0.0% | 15,000 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $16,000 | +6.7% | 15,000 | 0.0% | 0.01% | -27.3% |
| Q3 2019 | $15,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 36,000,000 | $36,583,000 | 5.85% |
| Man Investments (CH) AG | 3,200,000 | $3,250,000 | 2.78% |
| Verde Servicos Internacionais S.A. | 11,000,000 | $11,165,000 | 2.06% |
| Jabre Capital Partners S.A. | 10,000,000 | $10,156,000 | 1.97% |
| LINDEN ADVISORS LP | 38,500,000 | $39,095,000 | 1.39% |
| Opera Trading Capital | 9,900,000 | $9,925,000 | 1.35% |
| Sonora Investment Management, LLC | 4,950,000 | $5,029,596,000 | 0.87% |
| CQS Cayman LP | 10,000,000 | $10,165,000 | 0.68% |
| Polar Asset Management Partners Inc. | 25,000,000 | $25,384,000 | 0.51% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 26,000,000 | $26,383,000 | 0.50% |